Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
The EMBO Journal|July 4, 2019
GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite SuccinylacetoneFan Yang, Jingjing Li, Haijun Deng, et al.The Journal of Pathology|December 27, 2022
Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNAWei Wang, Xiaohui Zhu, Xuecong Zhang, et al.Gut|July 28, 2023
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunityYongsheng Li, Zhiyong Shen, Zhen Chai, et al.Journal of Medical Virology|February 27, 2023
Sphondin efficiently blocks HBsAg production and cccDNA transcription through promoting HBx degradationFang Ren, Junchi Hu, Yongjun Dang, et al.The Journal of Clinical Investigation|March 10, 2021
Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivationJin Xiang, Chang Chen, Rui Liu, et al.Theranostics|July 21, 2020
Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasisGengtai Ye, Qingbin Yang, Xuetao Lei, et al.Theranostics|January 8, 2019
Erratum: MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer: ErratumGengtai Ye, Kunzhai Huang, Jiang Yu, et al.Theranostics|September 14, 2017
MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric CancerGengtai Ye, Kunzhai Huang, Jiang Yu, et al.Gut|December 17, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8+ T cell dysfunctionKang Wu, Luo Li, Yi Liu, et al.Journal for Immunotherapy of Cancer|January 5, 2024
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter studyWeicai Huang, Wenjun Xiong, Lei Tang, et al.Pageof 13